Alerts will be sent to your verified email
Verify EmailJAGSNPHARM
Jagsonpal Pharma
|
Bliss GVS Pharma
|
Lincoln Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
12.82 % | 7.87 % | 15.94 % |
5yr average Equity Multiplier
|
1.29 | 1.33 | 1.3 |
5yr Average Asset Turnover Ratio
|
1.12 | 0.63 | 0.84 |
5yr Avg Net Profit Margin
|
8.95 % | 9.44 % | 14.61 % |
Price to Book
|
5.95 | 1.39 | 1.67 |
P/E
|
25.77 | 17.29 | 13.65 |
5yr Avg Cash Conversion Cycle
|
-0.27 Days | 169.17 Days | 24.49 Days |
Inventory Days
|
47.66 Days | 51.37 Days | 42.89 Days |
Days Receivable
|
25.88 Days | 187.07 Days | 90.22 Days |
Days Payable
|
68.7 Days | 75.42 Days | 111.35 Days |
5yr Average Interest Coverage Ratio
|
56.07 | 15.0 | 58.2 |
5yr Avg ROCE
|
17.0 % | 14.67 % | 20.48 % |
5yr Avg Operating Profit Margin
|
10.5 % | 17.43 % | 18.48 % |
5 yr average Debt to Equity
|
0.02 | 0.13 | 0.0 |
5yr CAGR Net Profit
|
23.34 % | -4.95 % | 12.65 % |
5yr Average Return on Assets
|
9.97 % | 5.91 % | 12.28 % |
Shareholdings
|
|||
Promoter Holding
|
67.78 % | 35.29 % | 49.78 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.93 % | 2.15 % | 7.73 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Jagsonpal Pharma
|
Bliss GVS Pharma
|
Lincoln Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|